Differential expression of glucocorticoid receptor in carcinomas of the human digestive systemLIEN, H.-C; LU, Y.-S; SHUN, C.-T et al.Histopathology. 2008, Vol 52, Num 3, pp 314-324, issn 0309-0167, 11 p.Article

Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - : significance of tumour cell clonality and BCLI0 expressionKUO, S.-H; CHEN, L.-T; LIN, J.-T et al.Journal of pathology. 2007, Vol 211, Num 3, pp 296-304, issn 0022-3417, 9 p.Article

Metaplastic carcinoma of the breast-analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancerKUO, S.-H; CHEN, C.-L; HUANG, C.-S et al.Anticancer research. 2000, Vol 20, Num 3B, pp 2219-2222, issn 0250-7005Article

Transactivation of the human MDR1 gene by hepatitis B virus X gene productDOONG, S.-L; LIN, M.-H; TSAI, M.-M et al.Journal of hepatology. 1998, Vol 29, Num 6, pp 872-878, issn 0168-8278Article

High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lungYEH, K.-H; CHENG, A.-L.Anticancer research. 1997, Vol 17, Num 2B, pp 1341-1343, issn 0250-7005Article

Cutaneous manifestations of postthymic T cell malignancies : description of five clinicopathologic subtypesSU, I.-J; WU, Y.-C; CHEN, Y.-C et al.Journal of the American Academy of Dermatology. 1990, Vol 23, Num 4, pp 653-662, issn 0190-9622, 10 p., 1Article

Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphomaYEH, K.-H; LIEN, H.-C; HSU, S.-M et al.American journal of hematology. 1999, Vol 60, Num 2, pp 161-163, issn 0361-8609Article

Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activityKUO, M.-L; SHEN, S.-C; YANG, C.-H et al.Oncogene (Basingstoke). 1998, Vol 17, Num 17, pp 2225-2234, issn 0950-9232Article

Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinomaCHENG, A.-L; YEH, K.-H; FINE, R. L et al.Hepato-gastroenterology. 1998, Vol 45, Num 24, pp 1955-1960, issn 0172-6390Conference Paper

Angioimmunoblastic lymphadenopathy with dysproteinemia : Lack of a prognostic value of clear cell morphologyCH'ANG, H.-J; SU, I.-J; CHEN, C.-L et al.Oncology. 1997, Vol 54, Num 3, pp 193-198, issn 0030-2414Article

A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancersYEH, K.-H; CHENG, A.-L; LIN, M.-T et al.Anticancer research. 1997, Vol 17, Num 5B, pp 3867-3871, issn 0250-7005Article

Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virusTSEN-FANG TSAI; IH-JEN SU; YAU-CHIN LU et al.Journal of the American Academy of Dermatology. 1992, Vol 26, Num 1, pp 31-37, issn 0190-9622Article

Menadione : spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell linesNUTTER, L. M; CHENG, A.-L; HSIAO-LING HUNG et al.Biochemical pharmacology. 1991, Vol 41, Num 9, pp 1283-1292, issn 0006-2952, 10 p.Article

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cellsCHEN, K.-F; LIU, C.-Y; LIN, Y.-C et al.Oncogene (Basingstoke). 2010, Vol 29, Num 47, pp 6257-6266, issn 0950-9232, 10 p.Article

Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide : the molecular mechanism and the clinical applicationLEE, J.-H; CHENG, A.-L; LIN, C.-W et al.British journal of dermatology (1951). 2009, Vol 160, Num 4, pp 887-889, issn 0007-0963, 3 p.Article

Differential expression of glucocorticoid receptor in human breast tissues and related neoplasmsLIEN, H.-C; LU, Y.-S; CHENG, A.-L et al.Journal of pathology. 2006, Vol 209, Num 3, pp 317-327, issn 0022-3417, 11 p.Article

Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIe large-cell lymphoma of the stomachLIU, H.-T; CHIUN HSU; CHEN, C.-L et al.American journal of hematology. 2000, Vol 64, Num 3, pp 175-179, issn 0361-8609Article

Concurrent chemoradiotherapy for locally advanced esophageal cancer : A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracilHSU, C.-H; YEH, K.-H; LOUIS TAK LUI et al.Anticancer research. 1999, Vol 19, Num 5C, pp 4463-4467, issn 0250-7005Article

Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL): A very effective regimen with good patients' compliance for advanced gastric cancerCHENG, A.-L; YEH, K.-H; LIN, J.-T et al.Anticancer research. 1998, Vol 18, Num 2B, pp 1267-1272, issn 0250-7005Article

Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancersYEH, K.-H; CHEN, C.-L; SHUN, C.-T et al.Journal of clinical gastroenterology. 1998, Vol 26, Num 4, pp 274-278, issn 0192-0790Article

Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instabilityWU, M.-S; SHEU, J.-C; SHUN, C.-T et al.Cancer letters. 1997, Vol 112, Num 2, pp 161-166, issn 0304-3835Article

Weekly CAF chemotherapy for advanced breast cancer patientsHWANG, W.-S; HSIUNG, C. A; CHENG, A.-L et al.Oncology. 1997, Vol 54, Num 4, pp 293-297, issn 0030-2414Article

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignanciesLIN, C.-C; SU, W.-C; VOSS, F et al.British journal of cancer. 2014, Vol 110, Num 10, pp 2434-2440, issn 0007-0920, 7 p.Article

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinomaSHEN, Y.-C; OU, D.-L; HSU, C et al.British journal of cancer. 2013, Vol 108, Num 1, pp 72-81, issn 0007-0920, 10 p.Article

Disseminated Peritoneal Leiomyomatosis Responds to Systemic ChemotherapyLIN, Y.-C; WEI, L.-H; SHUN, C.-T et al.Oncology. 2009, Vol 76, Num 1, pp 55-58, issn 0030-2414, 4 p.Article